Hotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities

Document Details

Document Type
Pub Defense Publication
Publication Date
Apr 01, 2020
Source ID
10.1016/j.celrep.2020.03.073

Entities

People

  • Adam B. Francisco
  • Andrew P. Massa
  • Charles G. Danko
  • F Donelson Smith
  • John D. Scott
  • Matt Kanke
  • Praveen Sethupathy
  • Ramja Sritharan
  • Rodica P. Bunaciu
  • Rosanna K. Ma
  • Timothy A. Dinh

Organizations

  • Fibrolamellar Cancer Foundation
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institutes of Health
  • United States Department of Defense